Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs
Crossref DOI link: https://doi.org/10.1186/s13561-025-00705-9
Published Online: 2025-11-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takamura, Kento
Jinnai, Gai
Niwa, Yuki
Kondoh, Masuo
Text and Data Mining valid from 2025-11-27
Version of Record valid from 2026-01-06
Article History
Received: 23 February 2025
Accepted: 14 November 2025
First Online: 27 November 2025
Declarations
:
: The authors declare no competing interests.